Title
Optimal Crossover Designs with Interactions between Treatments: Results from maximizing the trace of the information matrix of a,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
Many papers deal with the most common model for crossover designs, which typically include period, unit, direct treatment, and carryover effects. However, some authors argue the common model to be too simple in its assumptions and suggest that unit by treatment interaction may be of additional importance. Therefore, the interest of this doctoral thesis is to find optimal crossover designs in an unconstrained model with random assessor effects. The observations are assumed to be influenced by carryover effects and additional interactions between treatments and units. Kushner's method is applied in order to evaluate how interaction and carryover effects operate conjointly in an optimal crossover design. The method by Kushner maximizes the trace of the information matrix of the design on the basis of designdependent equivalence class functions. There are three equivalence classes of treatment sequences, which are crucial for the generation of an approximated optimal design if the number of periods does not exceed six.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.